0001171843-26-000979
SEC filingArbutus Biopharma Corporation filed an 8-K on February 20, 2026, disclosing a memorandum and order issued by the U.S. District Court for the District of Delaware on February 17, 2026, in litigation filed by Arbutus Biopharma. Exhibit 99.1 contains the court document.